These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 16452201
1. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N. Cancer Res; 2006 Feb 01; 66(3):1455-63. PubMed ID: 16452201 [Abstract] [Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D. Cancer Res; 2001 Feb 15; 61(4):1727-32. PubMed ID: 11245489 [Abstract] [Full Text] [Related]
3. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Ilan N, Elkin M, Vlodavsky I. Int J Biochem Cell Biol; 2006 Feb 15; 38(12):2018-39. PubMed ID: 16901744 [Abstract] [Full Text] [Related]
4. Regulation of heparanase gene expression by estrogen in breast cancer. Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T, Vlodavsky I, Kleinman HK. Cancer Res; 2003 Dec 15; 63(24):8821-6. PubMed ID: 14695198 [Abstract] [Full Text] [Related]
5. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Pal S, Datta K, Mukhopadhyay D. Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575 [Abstract] [Full Text] [Related]
6. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V. Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174 [Abstract] [Full Text] [Related]
7. Heparanase affects adhesive and tumorigenic potential of human glioma cells. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N. Cancer Res; 2003 Nov 15; 63(22):7733-41. PubMed ID: 14633698 [Abstract] [Full Text] [Related]
8. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. Harper J, Yan L, Loureiro RM, Wu I, Fang J, D'Amore PA, Moses MA. Cancer Res; 2007 Sep 15; 67(18):8736-41. PubMed ID: 17875714 [Abstract] [Full Text] [Related]
9. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I. J Natl Cancer Inst; 2004 Aug 18; 96(16):1219-30. PubMed ID: 15316057 [Abstract] [Full Text] [Related]
10. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, King PH. Cancer Res; 2008 Feb 01; 68(3):674-82. PubMed ID: 18245466 [Abstract] [Full Text] [Related]
11. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS. Cancer Res; 2005 Jul 01; 65(13):5881-9. PubMed ID: 15994966 [Abstract] [Full Text] [Related]
12. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D. Cancer Res; 2006 Feb 15; 66(4):2028-37. PubMed ID: 16489002 [Abstract] [Full Text] [Related]
13. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L. Mol Cancer Res; 2006 Jun 15; 4(6):371-7. PubMed ID: 16778084 [Abstract] [Full Text] [Related]
14. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas. Mikami S, Ohashi K, Katsube K, Nemoto T, Nakajima M, Okada Y. Pathol Int; 2004 Aug 15; 54(8):556-63. PubMed ID: 15260846 [Abstract] [Full Text] [Related]
15. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Shao Q, Wang H, McLachlan E, Veitch GI, Laird DW. Cancer Res; 2005 Apr 01; 65(7):2705-11. PubMed ID: 15805269 [Abstract] [Full Text] [Related]
16. Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression. Luan Q, Sun J, Li C, Zhang G, Lv Y, Wang G, Li C, Ma C, Gao T. Cancer Lett; 2011 Sep 01; 308(1):100-11. PubMed ID: 21624769 [Abstract] [Full Text] [Related]
17. HOXB7: a key factor for tumor-associated angiogenic switch. Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP. Cancer Res; 2001 Sep 01; 61(17):6532-9. PubMed ID: 11522651 [Abstract] [Full Text] [Related]
18. COX-2 induction by heparanase in the progression of breast cancer. Imada T, Matsuoka J, Nobuhisa T, Okawa T, Murata T, Tabuchi Y, Shirakawa Y, Ohara N, Gunduz M, Nagatsuka H, Umeoka T, Yamamoto Y, Nakajima M, Tanaka N, Naomoto Y. Int J Mol Med; 2006 Feb 01; 17(2):221-8. PubMed ID: 16391819 [Abstract] [Full Text] [Related]
19. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Nadir Y, Brenner B, Gingis-Velitski S, Levy-Adam F, Ilan N, Zcharia E, Nadir E, Vlodavsky I. Thromb Haemost; 2008 Jan 01; 99(1):133-41. PubMed ID: 18217145 [Abstract] [Full Text] [Related]
20. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y. Isr Med Assoc J; 2000 Jul 01; 2 Suppl():37-45. PubMed ID: 10909416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]